ArticleDigital health
Accelerating the performance of machine learning classifiers using bacterial colony optimization for heart disease prediction.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Cardiovascular Disease (CVD) remains one of the leading causes of global mortality, accounting for millions of deaths annually. Early and accurate diagnosis plays a critical role in reducing mortality and healthcare burden. However, conventional diagnostic approaches often suffer from misdiagnosis, delayed treatment, and increased medical costs. Machine Learning (ML) has shown significant potential in supporting clinical decision-making for early CVD detection. Nevertheless, ML models often face challenges such as computationally expensive parameter tuning and susceptibility to local minima. This study aims to address these challenges by proposing a bio-inspired optimization framework to enhance diagnostic accuracy and efficiency. Methods: This study employs Bacterial Colony Optimization (BCO) to optimize the hyperparameters of ten machine learning classifiers: Logistic Regression, Support Vector Machine (SVM), K-Nearest Neighbors, Multilayer Perceptron, Naïve Bayes, Random Forest (RF), Decision Tree, Extreme Gradient Boosting (XGBoost), Light Gradient Boosting Machine, and AdaBoost. Principal Component Analysis (PCA) is integrated to handle feature dimensionality and multicollinearity. Experiments were conducted using the Cleveland Heart Disease dataset (CLE) and the IEEE DataPort dataset (HGR), applying a rigorous 5-fold Cross-Validation (CV) strategy to ensure reliability and stability. Results: Experimental findings demonstrate that the integration of PCA, BCO, and ML classifiers significantly improves prediction performance compared to baseline models. The BCO-optimized RF model achieved the highest mean accuracy of 92.02% (95% CI: 89.93-94.10) on the HGR dataset, outperforming the baseline accuracy of 91.26%. Similarly, the BCO-SVM model achieved a mean accuracy of 85.79% on the CLE dataset. Confidence interval analysis further confirmed enhanced model stability and reduced prediction variance. Conclusion: The proposed framework effectively enhances CVD diagnosis by improving classification accuracy and stability. By efficiently exploring the search space and mitigating local minima limitations, the framework provides a statistically robust and clinically reliable decision-support tool for early cardiovascular risk detection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.